Managing invasive fungal disease in immunocompromised patients

被引：3

作者：

Maertens, Johan ^{[1
]}

Bryan, Jenny ^{[1
]}

机构：

[1] Univ Hosp Gasthuisberg, Dept Hematol, B-3000 Louvain, Belgium

来源：

FUTURE MICROBIOLOGY | 2010年 / 5卷 / 12期

关键词：

antifungal prophylaxis; aspergillosis; galactomannan; Immunocompromised; NEUTROPENIC PATIENTS; THERAPY;

D O I：

10.2217/FMB.10.142

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Report from the 16th International Symposium on Infections in the Immunocompromised Host Budapest, Hungary, 27-30 June 2010 Celebrating its 30th anniversary in Budapest this year, the International Immunocompromised Host Society (ICHS) was established to advance the understanding of interactions between host defenses and microbial agents in order to improve the prevention and management of human disease in patients with compromised immune function. Much has been achieved in the intervening years, and presentations on the challenges of invasive fungal disease at this year's ICHS congress reflected the changing nature of the population at risk of fungal disease, the growing range of fungal pathogens, and evolving approaches to the prevention, diagnosis and treatment of fungal infection.

引用

页码：1775 / 1779

页数：5